How to buy Atlassian (TEAM) stock from India

Yes, an Indian resident can buy Atlassian — legally, in USD, under the LRS. Clear one thing up first: Atlassian is Australian-incorporated and US-headquartered, but it is listed only on Nasdaq as TEAM, not on the ASX. For an Indian investor it is a US stock in every practical sense — same LRS plumbing, same Section 112 tax, same US-situs estate-tax trap. TEAM also has one helpful quirk: it pays no dividend, so withholding and Form 67 paperwork are essentially a non-issue. The short version below.

The 30-second version

• Legal and simple. Buy TEAM via an India-facing platform (Vested, INDmoney) or a global broker (Interactive Brokers, Rovia). Whole or fractional shares.
• Pure capital-gains play. TEAM has never paid a dividend and management has not signalled one, so US withholding and Form 67 are essentially irrelevant here.
• India tax: hold more than 24 months for 12.5% LTCG (no indexation); sell sooner and pay your slab rate. This is Section 112, not the friendlier 112A.
• The trap most miss: directly-held TEAM is a US-situs asset by virtue of its Nasdaq listing — above $60,000, your estate faces up to 40% US estate tax, with no India-US treaty relief.
• If your thesis is "US software," VTI and VOO hold TEAM at a small weight; IGV is the more concentrated route.

Quick facts

Can an Indian resident buy it?	Yes — fully legal under the LRS
Ticker / exchange	TEAM / Nasdaq (US listing; company is Australian-incorporated, US-HQ)
How	India-facing platform (Vested, INDmoney) or global broker (IBKR, Rovia)
Minimum	A fraction of one share (fractional lets you invest an exact rupee amount)
Dividend	None — TEAM has never paid one
India tax on gains	12.5% LTCG after 24 months; else your slab (Section 112)
Estate-tax risk	US-situs above $60k means up to 40%, no treaty relief
Annual compliance	Schedule FA disclosure, every year you hold

How to buy it — 3 steps

1. Open an account and finish KYC. Pick an India-facing platform (Vested, INDmoney) or a global broker (Interactive Brokers, Rovia). File your W-8BEN during onboarding — still good practice with no current dividend, because it covers any future distribution. New to this? Start with how to invest in US stocks from India.
2. Fund it via the LRS. Remit from your Indian bank under the LRS (cap: $250,000 per financial year). 20% TCS applies above ten lakh rupees in a year — a creditable prepayment, not a cost. See LRS explained and the LRS and TCS calculator.
3. Place the order. TEAM typically trades in a roughly $180-220 range, so one whole share is reachable on a single LRS remittance — or buy a fractional rupee amount.

The tax that actually matters

Atlassian pays no dividend, so the 25% US withholding and annual Form 67 foreign-tax-credit dance — a recurring headache with Microsoft or Apple — does not apply here. Your entire tax exposure is on capital gains when you sell, under Section 112 (foreign shares don't get the Section 112A treatment Indian-listed equity enjoys):

Holding period	Treatment	Rate
24 months or less	Short-term	Your slab rate (up to roughly 30% plus surcharge)
More than 24 months	Long-term	12.5%, no indexation

Worked example. Buy 10 shares at $190 when USD/INR is 86 → cost 1,63,400 rupees. Sell 27 months later at $215 when USD/INR is 88 → proceeds 1,89,200 rupees. Taxable gain 25,800 rupees; LTCG at 12.5% = 3,225 rupees. The gain is computed in rupees, so a weaker rupee at sale amplifies your reported gain even when the dollar move is modest. Model your own with the US capital-gains calculator; full rules in how US stocks are taxed in India. For Form 67 context (relevant if you also hold dividend-paying US names), see dividend withholding and Form 67.

The $60,000 estate-tax trap

Directly-held TEAM is a US-situs asset because the shares are listed and registered in the US — the Australian incorporation does not change this. If the holder dies with more than $60,000 of US-situs assets, the estate faces US estate tax up to 40% — and the India-US treaty does not cover estate tax, so there's no credit. The fix (holding through pooled or fund structures rather than direct shares) has to be a deliberate choice made before the position gets large. Full detail: the $60,000 estate-tax trap.

Buy the stock, or get Atlassian through an ETF?

If you want…	Best route
A concentrated bet that TEAM rerates as Rovo monetises	TEAM directly
Broad US software with TEAM as one of many	IGV (iShares Expanded Tech-Software)
"US large-cap" that incidentally holds TEAM	VTI or VOO — small weight, hundreds of names
Zero dividend-tax paperwork	TEAM works either way — it pays nothing
The least single-stock risk	A broad ETF

TEAM sits in VTI and VOO at a fractional weight and gets meaningfully more representation in software-focused ETFs like IGV. If your real thesis is "enterprise SaaS keeps compounding," IGV gives you TEAM plus the rest of the software stack — one Schedule FA entry, cleaner estate treatment via pooled vehicles. Compare the routes in direct stocks vs US ETFs and best US ETFs for Indian investors; the broader case is in US ETFs for Indians.

The business in one screen

What it is: Atlassian sells the default toolchain for enterprise software teams — Jira for issue tracking, Confluence for docs and team knowledge, Bitbucket for source control, Jira Service Management for ITSM, and Rovo, the AI layer that searches and reasons across all of it. Cloud migration is essentially done; the next leg has to come from Rovo monetisation, enterprise upsell, and defending Confluence against Notion.

Bull case	Bear case
Jira and Confluence still default in enterprise dev	Notion eating Confluence's lunch in modern teams
Rovo is a credible AI-on-your-own-data play	Linear taking Jira's developer mindshare
Cloud migration complete — capex and complexity behind it	Seat growth decelerating as customers consolidate vendors
Cash-flow generative; founder-led; high product velocity	Multiple still demanding for a decelerating top line
	Co-CEO founder model being tested at scale

Exact valuation is in the live widget above — a cash-generative platform priced for an AI-driven reacceleration not yet in the numbers.

Our take

Verdict: HOLD — the moat in enterprise dev workflows is real and Rovo is credible AI optionality, but growth is decelerating into a still-demanding multiple and the competitive perimeter is finally being tested.

• The moat still holds in the middle. Jira and Confluence are the default toolchain at most enterprise software orgs; switching costs around Jira workflows and integrations are real. Cloud migration is done, capex intensity is past peak, free cash flow is healthy.
• Rovo is the swing factor. An AI layer that searches and reasons across Jira, Confluence, and Bitbucket is the right product response — but monetisation, attach rates, and per-seat economics are unproven. Without a clean Rovo ramp, the multiple is hard to defend.
• Competition is finally showing up. Notion is winning modern docs and wikis for newer teams; Linear is taking developer mindshare from Jira. Seat growth is decelerating as customers consolidate SaaS vendors, and the founder-co-CEO model is being tested at scale for the first time. Cash flow holds; the rerating thesis needs Rovo to work.

Compliance note. Vested.blog is not a SEBI-registered Research Analyst. The above is an editorial opinion for educational illustration only — not investment advice and not a regulated stock recommendation. Vested.blog is published by Rovia; the publisher and its affiliates may hold positions in stocks discussed. Make your own decisions or consult a SEBI-registered advisor.

Risks to size for

• Competitive displacement: Notion in docs, Linear in issue tracking, plus a long tail of point tools — a single name takes the full hit if any of these break into the enterprise core.
• Rovo monetisation risk: if AI fails to convert into incremental ARR per seat, growth stays in the teens and the multiple compresses on a name still priced like high-growth SaaS.
• Currency: your return is in USD but you spend rupees — see the rupee-dollar effect.

Two things people forget

• Schedule FA: disclose TEAM in Schedule FA of your ITR every year you hold it — even if bought and sold within the year, even at a loss. Non-disclosure carries Black Money Act penalties. No dividend means no Form 67 for this position — but Schedule FA is non-negotiable. Use the Schedule FA helper.
• Position size: TEAM is a mid-cap software name with real competitive pressure, not a megacap compounder. Size it as a thesis-driven satellite, not a substitute for a broad ETF.

Bottom line

Buying TEAM from India is easy and legal. What needs thought isn't the buying — it's that TEAM is a Section-112 capital-gains play (12.5% after 24 months), a US-situs asset with a $60k estate-tax trap despite the Australian incorporation, and a mid-cap software name where the next leg depends on Rovo monetisation and defending Confluence against Notion. The upside: no dividend means no recurring 25% withholding and no Form 67 work. If your real thesis is "enterprise software keeps compounding," IGV gives the same exposure without the single-stock risk. For accounts and options, start at the US investing hub.

---

This article is general information, not personalised investment, tax, or legal advice. Rules, rates, and thresholds described here are as of 2026 and can change; verify the current position and consult a qualified advisor before acting.